Trial intelligence / Profile preview

Ozurdex as Adjunct to Avastin in Diabetic Macular Edema

NCT01309451Phase 4Completed

Sponsor
Raj K. Maturi MD
Start
Mar 2011
Primary completion
Apr 2013
Modality
Implantable Devices, Implantable Hydrogels, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ozurdex in diabetic macular edema (DME), sponsored by Raj K. Maturi MD. Started Mar 2011; status: completed.

02

Drugs

ozurdex
03

Conditions

diabetic macular edema (DME)

Beyond the preview

Go deeper on NCT01309451.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01309451.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call